High Risk for Bleeding in Older Patients Anticoagulated for Venous Thromboembolism
Researchers sought to determine bleeding risks for older patients treated with anticoagulation with vitamin K antagonists for the treatment of VTE.
Diagnosis & Disease Information
Blood Type May Predict Risk of Venous Thromboembolism Among Patients With Cancer
Researchers sought to determine whether ABO blood type may impact the risk of developing VTE in patients with cancer.
D-Dimer Testing Not Recommended for Determining Length of Required Treatment in Venous Thromboembolism
Researchers sought to determine whether using a D-dimer assay would help determine whether patients require extended treatment for VTE.
ICD Codes Unreliable for Identifying Cardiovascular Events in ICI-Treated Patients
Researchers sought to determine CV event occurrence in patients treated with immune checkpoint inhibitors and assess the accuracy of diagnosis by ICD code compared with adjudication using established definitions.
Apixaban Compared With Dalteparin in Cancer-Related Venous Thromboembolism
Researchers sought to compare oral apixaban and subcutaneous dalteparin for treating patients with cancer-related venous thromboembolism.
Immune Checkpoint Inhibitors May Not Increase Risk of Venous Thromboembolism
Researchers sought to determine whether immune checkpoint inhibitors would increase risk of VTE compared with chemotherapy among patients with cancer.
High Incidence of Anticoagulation-Associated Abnormal Menstrual Bleeding in Women After Venous Thromboembolism
Researchers sought to determine whether there was a link between abnormal menstrual bleeding and treatment with anticoagulants for VTE.
Strategies for VTE Prophylaxis in Cancer for Inpatient, Outpatient Settings
Recommendations for venous thromboembolism prophylaxis in patients with cancer were discussed in an oral session at JADPRO Live 2022.
Risk of VTE 6-Fold Higher in CLL/MBL Than in General Population
Patients with chronic lymphocytic leukemia or monoclonal B-cell lymphocytosis have an increased risk of venous thromboembolism, a study suggests.
Low-Quality Evidence Underlies Use of Intermittent Pneumatic Compression With Pharmacological Thromboprophylaxis for VTE
Researchers sought to determine whether the addition of IPC to thromboprophylaxis for prevention of VTE is based on sound evidence.
- Loading...
Loading...
Next post in Thrombotic Disorders
Loading... 
Loading...